Rare diseases of phosphate and calcium metabolism: Crossing glances between nephrology and endocrinology
Autor: | Aurélia Bertholet-Thomas, Mélodie Mosca, Julie Bernardor, Sandrine Lemoine, Justine Bacchetta |
---|---|
Přispěvatelé: | Centre de référence des maladies rénales rares Néphrogones [CHU-HCL, Lyon], Hôpital Femme Mère Enfant [CHU - HCL] (HFME), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Physiopathologie, diagnostic et traitements des maladies osseuses / Pathophysiology, Diagnosis & Treatments of Bone Diseases (LYOS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital l'Archet, Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), Université de Lyon, CarMeN, laboratoire |
Rok vydání: | 2021 |
Předmět: |
Nephrology
X-linked hypophosphatemia medicine.medical_specialty Hypoparathyroidism Hypoparathyroïdie [SDV]Life Sciences [q-bio] Endocrinology Diabetes and Metabolism Phosphate 030209 endocrinology & metabolism Context (language use) Nephrolithiasis Kidney urologic and male genital diseases Hypophosphatémie liée à l’X Phosphates Lithiase 03 medical and health sciences Hyperphosphatemia Rare Diseases 0302 clinical medicine Endocrinology Calcium Metabolism Disorders Internal medicine medicine Teriparatide Humans Hypercalciuria Patient Care Team Calcium metabolism business.industry Hyperparathyroidism Phosphorus Metabolism Disorders General Medicine medicine.disease 3. Good health [SDV] Life Sciences [q-bio] Hyperparathyroïdie medicine.anatomical_structure 030220 oncology & carcinogenesis Phosphore Rein Calcium Interdisciplinary Communication business medicine.drug |
Zdroj: | Annales d'Endocrinologie Annales d'Endocrinologie, Elsevier Masson, 2020, 82 (1), pp.30-35. ⟨10.1016/j.ando.2020.12.005⟩ |
ISSN: | 0003-4266 2213-3941 |
Popis: | International audience; Rare diseases of phosphate/calcium metabolism correspond to a wide and heterogeneous spectrum of diseases. Recent knowledge in physiology and genetics has made it possible to better characterize them and to propose attractive therapeutic approaches based on the underlying pathophysiology. These diseases are often at the interface between nephrology and endocrinology. In this spirit of a multidisciplinary care, each specialty can bring its own critical point of view and its own specificities to improve patient care. The objective of this manuscript is to "read" with a nephrologist's point of view the main frameworks of diseases of phosphate/calcium metabolism, to illustrate the three crucial messages of nephro-protection sent to endocrinologists. First, calciuria must be interpreted both in absolute value (concentration hypercalciuria) and in ratio (flow hypercalciuria). Second, renal monitoring of therapies inducing hypercalciuria on kidneys with normal renal function (e.g. active vitamin D analogs or teriparatide) should be systematic. Last, hyperphosphatemia, often latent in hypoparathyroidism and pseudo-hypoparathyroidism, should be detected and at least benefit from dietary measures, in the context of Western diets rich in phosphate hidden in food additives. |
Databáze: | OpenAIRE |
Externí odkaz: |